CN Stock MarketDetailed Quotes

688506 Sichuan Biokin Pharmaceutical

Watchlist
  • 190.59
  • +4.43+2.38%
Trading May 14 13:13 CST
76.43BMarket Cap17.40P/E (TTM)

Sichuan Biokin Pharmaceutical Key Stats

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Total operating revenue
4,325.45%5.46B
-20.11%561.87M
-21.37%377.7M
2.06%311.04M
1.74%123.43M
-11.73%703.28M
-21.75%480.34M
-27.97%304.76M
121.31M
-21.33%796.73M
Operating revenue
4,325.45%5.46B
-20.11%561.87M
-21.37%377.7M
2.06%311.04M
1.74%123.43M
-11.73%703.28M
-21.75%480.34M
-27.97%304.76M
--121.31M
-21.33%796.73M
Total operating cost
29.87%386.89M
31.36%1.37B
26.45%943.85M
43.32%656.84M
65.18%297.91M
8.26%1.05B
7.13%746.41M
458.3M
180.35M
-8.38%966.58M
Operating cost
25.75%58.92M
-1.48%229.28M
-4.02%145.2M
29.79%112.3M
56.72%46.85M
17.71%232.74M
6.43%151.29M
-4.31%86.53M
--29.9M
-1.60%197.73M
Operating tax surcharges
127.81%3.25M
-23.34%10.48M
-40.62%5.42M
-12.38%4.81M
-36.67%1.43M
-3.29%13.67M
-16.98%9.12M
--5.49M
--2.25M
-12.49%14.14M
Operating expense
0.54%58.03M
-22.54%251.19M
-20.83%179.72M
-3.14%140.89M
4.98%57.72M
-17.12%324.3M
-25.58%227.01M
--145.46M
--54.98M
-32.12%391.3M
Administration expense
1.14%27.18M
48.26%116.7M
47.97%88.41M
46.16%55.42M
48.70%26.87M
3.35%78.71M
8.07%59.75M
--37.92M
--18.07M
26.05%76.16M
Financial expense
-251.96%-9.26M
-5.70%20.76M
-2.20%15.3M
9.24%10.57M
40.32%6.09M
154.18%22.02M
168.15%15.65M
--9.68M
--4.34M
62.14%8.66M
-Interest expense (Financial expense)
12.14%7.14M
9.78%24.68M
15.42%18.49M
25.85%12.53M
42.72%6.37M
158.64%22.48M
179.95%16.02M
--9.96M
--4.46M
14.87%8.69M
-Interest Income (Financial expense)
-3,673.16%-21.01M
-643.96%-5.7M
-660.04%-4.37M
-631.01%-2.83M
-161.13%-556.88K
-61.45%-766.6K
-140.94%-575.4K
---386.63K
---213.26K
78.47%-474.83K
Research and development
56.52%248.77M
98.98%746.23M
79.77%509.8M
92.14%332.83M
124.47%158.94M
34.61%375.02M
59.82%283.59M
53.69%173.23M
--70.8M
42.36%278.6M
Credit Impairment Loss
-115.45%-263.11K
183.82%6.44M
313.08%6.22M
221.57%1.71M
408.63%1.7M
-356.32%-7.69M
-208.23%-2.92M
---1.41M
--334.83K
48.76%3M
Asset Impairment Loss
-23.87%-5.86M
-161.45%-12.98M
-145.14%-9.63M
-146.81%-6.12M
-374.12%-4.73M
12.44%-4.96M
-13.62%-3.93M
---2.48M
---997.35K
-428.06%-5.67M
Other net revenue
Invest income
----
--3.9K
--3.9K
--3.9K
--3.9K
----
----
----
----
23.60%3.14M
Asset deal income
----
853.26%146.39K
853.26%146.39K
853.26%146.39K
853.26%146.39K
-308.89%-19.43K
-308.89%-19.43K
---19.43K
---19.43K
--9.3K
Other revenue
233.64%4.21M
-27.01%49.79M
49.71%35.15M
-66.07%6.79M
-93.14%1.26M
0.44%68.21M
-59.35%23.48M
--20.02M
--18.4M
-20.25%67.91M
Operating profit
2,981.04%5.07B
-167.48%-769.38M
-114.17%-534.25M
-149.76%-343.25M
-326.22%-176.09M
-183.49%-287.63M
-996.27%-249.46M
-418.56%-137.43M
-41.32M
-317.32%-101.46M
Add:Non operating Income
-98.32%17.93K
3,461.65%2.3M
4,523.39%2.29M
4,820.73%2.27M
2,852.26%1.07M
-57.25%64.62K
-57.98%49.48K
--46.11K
--36.1K
-79.31%151.15K
Less:Non operating expense
-63.18%145.65K
28.89%1.94M
25.07%1.73M
-53.09%621.36K
-63.66%395.53K
-51.90%1.5M
-50.70%1.38M
--1.32M
--1.09M
73.92%3.13M
Total profit
2,991.97%5.07B
-166.03%-769.01M
-112.81%-533.7M
-146.27%-341.61M
-314.05%-175.42M
-176.79%-289.07M
-885.76%-250.79M
-379.09%-138.71M
-42.37M
-328.92%-104.44M
Less:Income tax cost
891.75%68.04M
271.57%11.49M
-132.85%-18.59M
-1,210.80%-13.29M
-367.30%-8.59M
-50.60%-6.69M
-229.45%-7.98M
---1.01M
--3.21M
-157.74%-4.45M
Net profit
FLtoP5.01B
FPtoL-780.5M
FPtoL-515.11M
FPtoL-328.32M
FPtoL-166.83M
FPtoL-282.38M
FPtoL-242.81M
FPtoL-137.7M
-45.58M
SL-99.99M
Net profit from continuing operation
3,100.16%5.01B
-176.40%-780.5M
-112.15%-515.11M
-138.43%-328.32M
-265.99%-166.83M
-182.40%-282.38M
-954.86%-242.81M
---137.7M
---45.58M
-363.67%-99.99M
Net profit of parent company owners
3,100.16%5.01B
-176.40%-780.5M
-112.15%-515.11M
-138.43%-328.32M
-265.99%-166.83M
-182.40%-282.38M
-954.86%-242.81M
-486.36%-137.7M
---45.58M
-363.82%-99.99M
Earning per share
Basic earning per share
3,071.43%12.48
-150.00%-1.95
-91.04%-1.28
-115.79%-0.82
-223.08%-0.42
-178.57%-0.78
-1,016.67%-0.67
---0.38
---0.13
-354.55%-0.28
Diluted earning per share
3,071.43%12.48
-150.00%-1.95
-91.04%-1.28
-115.79%-0.82
-223.08%-0.42
-178.57%-0.78
-1,016.67%-0.67
---0.38
---0.13
-354.55%-0.28
Other composite income
56.28%-1.45M
-4,972.93%-1.67M
-183.46%-2.41M
-463.35%-2.66M
-4,383.76%-3.31M
110.16%34.22K
2,305.20%2.89M
731.66K
77.25K
83.36%-336.67K
Other composite income of parent company owners
56.28%-1.45M
-4,972.93%-1.67M
-183.46%-2.41M
-463.35%-2.66M
-4,383.76%-3.31M
110.16%34.22K
2,305.20%2.89M
--731.66K
--77.25K
83.36%-336.67K
Total composite income
3,040.95%5B
-177.03%-782.17M
-115.70%-517.51M
-141.65%-330.98M
-273.89%-170.14M
-181.42%-282.34M
-947.78%-239.92M
-136.97M
-45.51M
-379.47%-100.33M
Total composite income of parent company owners
3,040.95%5B
-177.03%-782.17M
-115.70%-517.51M
-141.65%-330.98M
-273.89%-170.14M
-181.42%-282.34M
-947.78%-239.92M
---136.97M
---45.51M
-379.63%-100.33M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Total operating revenue 4,325.45%5.46B-20.11%561.87M-21.37%377.7M2.06%311.04M1.74%123.43M-11.73%703.28M-21.75%480.34M-27.97%304.76M121.31M-21.33%796.73M
Operating revenue 4,325.45%5.46B-20.11%561.87M-21.37%377.7M2.06%311.04M1.74%123.43M-11.73%703.28M-21.75%480.34M-27.97%304.76M--121.31M-21.33%796.73M
Total operating cost 29.87%386.89M31.36%1.37B26.45%943.85M43.32%656.84M65.18%297.91M8.26%1.05B7.13%746.41M458.3M180.35M-8.38%966.58M
Operating cost 25.75%58.92M-1.48%229.28M-4.02%145.2M29.79%112.3M56.72%46.85M17.71%232.74M6.43%151.29M-4.31%86.53M--29.9M-1.60%197.73M
Operating tax surcharges 127.81%3.25M-23.34%10.48M-40.62%5.42M-12.38%4.81M-36.67%1.43M-3.29%13.67M-16.98%9.12M--5.49M--2.25M-12.49%14.14M
Operating expense 0.54%58.03M-22.54%251.19M-20.83%179.72M-3.14%140.89M4.98%57.72M-17.12%324.3M-25.58%227.01M--145.46M--54.98M-32.12%391.3M
Administration expense 1.14%27.18M48.26%116.7M47.97%88.41M46.16%55.42M48.70%26.87M3.35%78.71M8.07%59.75M--37.92M--18.07M26.05%76.16M
Financial expense -251.96%-9.26M-5.70%20.76M-2.20%15.3M9.24%10.57M40.32%6.09M154.18%22.02M168.15%15.65M--9.68M--4.34M62.14%8.66M
-Interest expense (Financial expense) 12.14%7.14M9.78%24.68M15.42%18.49M25.85%12.53M42.72%6.37M158.64%22.48M179.95%16.02M--9.96M--4.46M14.87%8.69M
-Interest Income (Financial expense) -3,673.16%-21.01M-643.96%-5.7M-660.04%-4.37M-631.01%-2.83M-161.13%-556.88K-61.45%-766.6K-140.94%-575.4K---386.63K---213.26K78.47%-474.83K
Research and development 56.52%248.77M98.98%746.23M79.77%509.8M92.14%332.83M124.47%158.94M34.61%375.02M59.82%283.59M53.69%173.23M--70.8M42.36%278.6M
Credit Impairment Loss -115.45%-263.11K183.82%6.44M313.08%6.22M221.57%1.71M408.63%1.7M-356.32%-7.69M-208.23%-2.92M---1.41M--334.83K48.76%3M
Asset Impairment Loss -23.87%-5.86M-161.45%-12.98M-145.14%-9.63M-146.81%-6.12M-374.12%-4.73M12.44%-4.96M-13.62%-3.93M---2.48M---997.35K-428.06%-5.67M
Other net revenue
Invest income ------3.9K--3.9K--3.9K--3.9K----------------23.60%3.14M
Asset deal income ----853.26%146.39K853.26%146.39K853.26%146.39K853.26%146.39K-308.89%-19.43K-308.89%-19.43K---19.43K---19.43K--9.3K
Other revenue 233.64%4.21M-27.01%49.79M49.71%35.15M-66.07%6.79M-93.14%1.26M0.44%68.21M-59.35%23.48M--20.02M--18.4M-20.25%67.91M
Operating profit 2,981.04%5.07B-167.48%-769.38M-114.17%-534.25M-149.76%-343.25M-326.22%-176.09M-183.49%-287.63M-996.27%-249.46M-418.56%-137.43M-41.32M-317.32%-101.46M
Add:Non operating Income -98.32%17.93K3,461.65%2.3M4,523.39%2.29M4,820.73%2.27M2,852.26%1.07M-57.25%64.62K-57.98%49.48K--46.11K--36.1K-79.31%151.15K
Less:Non operating expense -63.18%145.65K28.89%1.94M25.07%1.73M-53.09%621.36K-63.66%395.53K-51.90%1.5M-50.70%1.38M--1.32M--1.09M73.92%3.13M
Total profit 2,991.97%5.07B-166.03%-769.01M-112.81%-533.7M-146.27%-341.61M-314.05%-175.42M-176.79%-289.07M-885.76%-250.79M-379.09%-138.71M-42.37M-328.92%-104.44M
Less:Income tax cost 891.75%68.04M271.57%11.49M-132.85%-18.59M-1,210.80%-13.29M-367.30%-8.59M-50.60%-6.69M-229.45%-7.98M---1.01M--3.21M-157.74%-4.45M
Net profit FLtoP5.01BFPtoL-780.5MFPtoL-515.11MFPtoL-328.32MFPtoL-166.83MFPtoL-282.38MFPtoL-242.81MFPtoL-137.7M-45.58MSL-99.99M
Net profit from continuing operation 3,100.16%5.01B-176.40%-780.5M-112.15%-515.11M-138.43%-328.32M-265.99%-166.83M-182.40%-282.38M-954.86%-242.81M---137.7M---45.58M-363.67%-99.99M
Net profit of parent company owners 3,100.16%5.01B-176.40%-780.5M-112.15%-515.11M-138.43%-328.32M-265.99%-166.83M-182.40%-282.38M-954.86%-242.81M-486.36%-137.7M---45.58M-363.82%-99.99M
Earning per share
Basic earning per share 3,071.43%12.48-150.00%-1.95-91.04%-1.28-115.79%-0.82-223.08%-0.42-178.57%-0.78-1,016.67%-0.67---0.38---0.13-354.55%-0.28
Diluted earning per share 3,071.43%12.48-150.00%-1.95-91.04%-1.28-115.79%-0.82-223.08%-0.42-178.57%-0.78-1,016.67%-0.67---0.38---0.13-354.55%-0.28
Other composite income 56.28%-1.45M-4,972.93%-1.67M-183.46%-2.41M-463.35%-2.66M-4,383.76%-3.31M110.16%34.22K2,305.20%2.89M731.66K77.25K83.36%-336.67K
Other composite income of parent company owners 56.28%-1.45M-4,972.93%-1.67M-183.46%-2.41M-463.35%-2.66M-4,383.76%-3.31M110.16%34.22K2,305.20%2.89M--731.66K--77.25K83.36%-336.67K
Total composite income 3,040.95%5B-177.03%-782.17M-115.70%-517.51M-141.65%-330.98M-273.89%-170.14M-181.42%-282.34M-947.78%-239.92M-136.97M-45.51M-379.47%-100.33M
Total composite income of parent company owners 3,040.95%5B-177.03%-782.17M-115.70%-517.51M-141.65%-330.98M-273.89%-170.14M-181.42%-282.34M-947.78%-239.92M---136.97M---45.51M-379.63%-100.33M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg